New York, April 10, 2023 (GLOBE NEWSWIRE) -- According to Market.us, The veterinary vaccines market size is projected to surpass around USD 22.1 billion by 2032 from USD 11.2 billion in 2022, and it is poised to reach a CAGR of 7.2% from 2023 to 2032. Veterinary vaccines are used for treating and avoiding lifetime-threatening diseases in animals. These vaccines help decrease animal suffering and the transmission of diseases that cause microorganisms in the animal population. These vaccines are mainly used to develop the immunity power of animals which further protects the transmission of diseases from animals to humans. Veterinary vaccines signify bio-prepared immunizations administered to animals through the oral or parenteral route.
Get a holistic overview of Veterinary Vaccines Market by industry experts to evaluate and develop growth strategies. Download the Sample - https://market.us/report/veterinary-vaccine-market/request-sample/
Key Takeaway:
- By Product, the recombinant segment generated a revenue share of 35% in 2022.
- By Animal, the companion segment exhibited the highest CAGR during the forecast period 2023 to 2032
- By Route of Administration, the parenteral segment generated a revenue share of 52% in 2022.
- By Disease Indication, the porcine reproductive and respiratory segment generated the highest revenue share in 2022.
- By Distribution Channel, the veterinary hospital segment has dominated the market, and it is growing at the largest CAGR over the forecast period 2023 to 2032.
- In 2022, North America dominated the market with the highest revenue share of 40%.
- Europe held a 32% revenue share in 2022.
- Asia-Pacific will grow at a CAGR of 7.4% from 2023-2032.
In most cases, animal vaccination is done as proactively as possible to provide animal health safety from viruses. Key factors boosting the market growth are the rising incidence of zoonotic disease and the increasing prevalence of the disease.
Factors affecting the growth of the Veterinary Vaccines Market
There are several factors that can affect the growth of the veterinary vaccines market. Some of these factors include:
- Increasing pet adoption rate: Pets are considered family members and ideal companions for aging. Increased pet approval will increase the vaccine requirement, propelling the market growth.
- A rise in the number of R&D activities: The increase in research& development activities for planning efficient, effective, and high-quality vaccines for companion and farm animals and the launch of new products will offer helpful growth for the veterinary vaccines market.
- Growth in Technological Advancement: Technological Advancement in the development of animal health vaccines and an increase in emerging markets will further provide positive growth.
if you need a more focused analysis of a particular region or segment, our analysts can customize the report to meet your specific requirements. Feel free to contact us for further assistance @ https://market.us/report/veterinary-vaccine-market/#inquiry
Top Trends in Global Veterinary Vaccines Market
Technical developments in animal immunization growth are a key trend in the global veterinary vaccines market. One of the significant developments to date is the introduction of DNA and other vaccines. Additionally, cutting-edge technology has made it possible to benefit from increased constancy and administration simplicity. The direct injection of messenger RNA or the cloning of DNA into delivery plasmid are the foundations of these products. The rising efforts by vendors to collaborate with academic institutions to develop innovative products is the key factor for veterinary vaccines market trends that will gain pull in the veterinary vaccines market.
Market Growth
The growth of this market is mainly due to the rise in the companion animal population, initiatives by various government agencies, and increasing zoonotic disease. Rising requirement agencies and products are boosting market growth. In developing economies, technical invention and increasing awareness of animal health are estimated to offer lucrative growth in the upcoming years. Rise in government and global animal husbandry programs, and increase in animal ownership amongst individuals are reasons the market is anticipated to drive the global market.
Regional Analysis
The veterinary vaccines market was dominated by North America, which acquired the most significant revenue share. This growth primarily results from factors such as the rising dominance of zoonotic disease, favorable compensation programs, and due to beneficial government guidelines such as the increased approval of pet insurance, the rising number of veterinary clinics, and enhanced healthcare infrastructure in European countries. Europe is considered the second-largest regional market. Asia-Pacific is projected to witness the largest growth in the market. Due to growing disposable incomes across the region, there is more awareness regarding protective animal healthcare. On the other hand, the Middle East & Africa, and Latin regions are to witness stable growth rates throughout the forecast period.
To know about the regional trends and drivers that will have an impact on the market - Request a sample report!
Scope of the Report
| Report Attribute | Details |
| Market Value (2022)USD 44.8 Billion | USD 11.2 Billion |
| Market Size (2032) | USD 22.1 Billion |
| CAGR (from 2022 to 2032) | 7.2% |
| North America Revenue Share | 40% |
| Europe Revenue Share | 32% |
| Historic Period | 2016 to 2022 |
| Base Year | 2022 |
| Forecast Year | 2023 to 2032 |
Market Drivers
One of the primary drivers for the rapidly increasing size of the veterinary vaccines market is a rise in animal husbandry initiatives and increased awareness of veterinary healthcare. Rising awareness and the invention of new inoculation products boost market growth. The introduction of animal products and subsequent technological advancements are significant driving factors. The prevention of animal diseases that have the potential to spread to humans and cause epidemics results in a public health crisis. Since its introduction to the general public, animal immunization has undergone significant R&D advancements.
Market Restraints
In developing nations, millions of smallholder farmers are projected to own livestock. Smallholder farmers face additional financial strain due to the numerous disease that kills their livestock. These smallholder farmers have a hard time immunizing their animals because they aren’t aware of the benefits and cannot afford the inoculation products. Governments and agencies are employing various strategies to increase accessibility and approval of immunization among smallholder farmers. Lack of vaccination adoption among smallholder farmers in developing countries may hamper growth.
Market Opportunities
In the current scenario, several positive factors provide lucrative opportunities for the growth of the veterinary vaccines market. Veterinary vaccines play a significant role in animal health protection by preventing serious epizootic disease. Rising approval of efficient immunizations and higher spending on part care are the main contributors to market growth. Vaccine development is essential for the emergence of different animal diseases. The rise in pet ownership has significantly enhanced the growth of the market.
Immediate Delivery Available | Buy This Premium Research Report@ https://market.us/purchase-report/?report_id=20089
Report Segmentation of the Veterinary Vaccines Market
Product Insight
The recombinant segment dominated the veterinary vaccines market, which also held the greatest revenue share. Owing to their positive features such as efficacy, safety, and potency. Some influences that have caused the recombinant segments' development are the manufacturers' lucrative production capability to produce a developed and higher quality. The further benefit over conventional immunization products is that recombinant dose tolerates the immune system to focus its antibody production over the significant antigens.
Animal Insight
The companion segment accounted largest market share. Due to the rising pet animal ownership across the world. Primarily due to the increasing pet ownership across the world. The overall development of animal adoption is another factor contributing to the growth of the animal companion section. Companion animal vaccination is one of the most common veterinary processes undertaken worldwide. Especially owing to rising awareness and concerned animal owners.
Route of Administration Insight
The Parenteral segment is anticipated to generate the highest revenue in the market. Parenteral animal vaccinations contain major routes such as intramuscular and intradermal. In addition, this segment further propels market growth due to technological advances in immunization delivery devices.
Disease Insight
The porcine reproductive and respiratory segments dominated the market growth due to the high and increasing prevalence of the infection.
Distribution Insight
The veterinary clinic segment accounted for the highest share. Vaccinations are often a short-duration process that is conducted at smaller institutions.
If you want to get a better understanding of the report, you can access a PDF sample, which includes the complete table of contents, list of exhibits, selected illustrations, and example pages @ https://market.us/report/veterinary-vaccine-market/request-sample/
Market Segmentation
By Product
- Attenuated Live Vaccines
- Inactivated
- Toxoid Vaccines
- Recombinant Vaccines
- Subunit Vaccines
- Conjugate Vaccines
- DNA Vaccines
By Animal
- Porcine Vaccine
- Poultry Vaccine
- Livestock Vaccine
- Bovine Vaccines
- Small Ruminant Vaccine
- Companion Animal Vaccine
- Canine Vaccine
- Feline Vaccine
- Aquaculture Vaccines
- Other Animal Vaccine
By Route of Administration
- Oral
- Parenteral
- Others
By Disease Indication
- Porcine Reproductive and Respiratory Syndrome
- Avian Influenza
- Rabies
- Coccidiosis
- Swine Pneumonia
- Brucellosis
- Canine Parvovirus
- Anaplasmosis
- Distemper Disease
- Foot and Mouth Disease
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies
- Drug Stores
- Others
By Geography
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Competitive Landscape
The competitive landscape of the market has also been examined in this report. Some of the major players include
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- HIPRA
- Merck& Co, Inc.
- Virbac
- Vetoqional S. A
- ADM Animal Nutrition
- Evonik Industries AG
- Zoetis Inc.
- MSD Animal Health
- Hester Biosciences Limited
- Ceva Logistics
- Neogen Corporation Limited
- Biogenesis Bago S A
- Kindered Biosciences, Inc.
- Bayer AG
- Indian Immunologicals Ltd
- Eli Lilly and Company
- Phibro Animal Health Corporation
- Other Key Players
Recent Development of the Veterinary Vaccines Market
- In November 2020, HIPRA declared the virtual launch of GUMBOHATCH’s innovative generation Infectious Bursal Disease complex immunization product for boiler chickens.
- In September 2020, Hester Biosciences Limited declared the Brucella vaccine development, conforming lifetime immunity in calf-hood. However, the company signed with the Indian Veterinary Institute and the Council of Agriculture to obtain the indigenously established emerging Brucella Aborts 19n Delta per dose.
Browse More Related Reports:
- Swine Vaccines Market size is expected to be worth around USD 2.58 million by 2032 from USD 2 million in 2023, growing at a CAGR of 4.20%
- Brucellosis Vaccines Market is valued USD 313.9 Mn and is expected to be reach USD 439 Mn in 2032, with a CAGR 3.8% from 2022 to 2032.
- Animal Vaccines Market was valued at USD 11,657 million in 2021. This number is projected to increase at a compound annual growth rate (CAGR) of 8.7% Between 2023 & 2032.
- Poultry Vaccines Market was valued at USD 1,825 million in 2021. The market is forecast to grow at a 6.6% CAGR.
- Live Cell Imaging Market was valued at US$ 2.8 Billion in 2022. this market is estimated to register the highest CAGR of 9.4% Between 2023 and 2032.
- Life science analytics market was valued at US$ 9 billion in 2022. this market is estimated to register a CAGR of 8% Between 2023 & 2032.
About Us:
Market.US (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
Follow Us on LinkedIn | Facebook | Twitter
Our Blog:
